In this review:
IL28B polymorphisms affect outcome after liver transplantation in HCV patients
Early HCV viral kinetics in a study of PEG-IFN-ë
Telaprevir-based regimens in patients with HCV (ILLUMINATE)
Boceprevir plus P/R for genotype 1 HCV (SPRINT-2)
GS-9256/GS-9190/r
Please login below to download this issue (PDF)